Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 132 participants.

Also called NCT03183895

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 132 participants (planned count) (from the registry)
Sponsor
Ancora Heart, Inc. (from the registry)
Registry
  • NCT NCT03183895
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belarus, Belgium, Czechia, France, Italy, Lithuania, Netherlands, Poland, Switzerland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03183895. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-15 (actual); primary completion 2026-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study
Condition
Heart Failure
Condition
Cardiomyopathies
Intervention (Device)
Left ventricular restoration
Lead sponsor
Ancora Heart, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03183895
Content hash
8362fbef180ab8c9c669a1985655ca082a654057c4d43f6535a94f7bd74c5cb8